Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vaccines, Virus-Like Particle | 3 | 2018 | 312 | 1.16 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 2 | 2018 | 386 | 1.07 | Why? |
| HIV Antibodies | 2 | 2018 | 776 | 0.89 | Why? |
| AIDS Vaccines | 3 | 2018 | 452 | 0.73 | Why? |
| T-Lymphocytes, Helper-Inducer | 2 | 2018 | 497 | 0.68 | Why? |
| HIV-1 | 3 | 2018 | 3365 | 0.56 | Why? |
| Immunization, Secondary | 5 | 2021 | 1649 | 0.38 | Why? |
| Antibody Formation | 2 | 2018 | 4038 | 0.37 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.27 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.23 | Why? |
| Receptors, CCR4 | 1 | 2021 | 42 | 0.23 | Why? |
| HIV Envelope Protein gp41 | 1 | 2012 | 153 | 0.22 | Why? |
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2020 | 106 | 0.20 | Why? |
| B-Lymphocytes | 3 | 2021 | 4418 | 0.20 | Why? |
| Nucleoproteins | 1 | 2021 | 223 | 0.19 | Why? |
| Protein Engineering | 1 | 2012 | 536 | 0.19 | Why? |
| Fusion Proteins, gag-pol | 1 | 2017 | 6 | 0.18 | Why? |
| SAIDS Vaccines | 1 | 2017 | 25 | 0.18 | Why? |
| HIV Core Protein p24 | 1 | 2017 | 48 | 0.18 | Why? |
| Gene Products, env | 1 | 2017 | 74 | 0.17 | Why? |
| Antibodies, Viral | 7 | 2021 | 51949 | 0.17 | Why? |
| Transport Vesicles | 1 | 2007 | 27 | 0.17 | Why? |
| Newcastle disease virus | 1 | 2017 | 108 | 0.17 | Why? |
| Cell Membrane | 1 | 2012 | 743 | 0.16 | Why? |
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 552 | 0.16 | Why? |
| Membrane Glycoproteins | 2 | 2007 | 2273 | 0.16 | Why? |
| Simian Acquired Immunodeficiency Syndrome | 1 | 2017 | 154 | 0.16 | Why? |
| Parainfluenza Virus 3, Human | 1 | 2005 | 67 | 0.15 | Why? |
| Immune System Diseases | 1 | 2020 | 410 | 0.15 | Why? |
| Croup | 1 | 2005 | 44 | 0.15 | Why? |
| CD4-Positive T-Lymphocytes | 3 | 2021 | 4545 | 0.15 | Why? |
| Cell Communication | 1 | 2017 | 396 | 0.15 | Why? |
| Simian Immunodeficiency Virus | 1 | 2017 | 251 | 0.14 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2017 | 424 | 0.14 | Why? |
| Common Cold | 1 | 2021 | 645 | 0.14 | Why? |
| Glioma | 1 | 2017 | 189 | 0.14 | Why? |
| Intestines | 1 | 2021 | 817 | 0.14 | Why? |
| Complement Activation | 1 | 2021 | 949 | 0.13 | Why? |
| HIV | 1 | 2021 | 1116 | 0.13 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2021 | 5837 | 0.13 | Why? |
| Viral Envelope Proteins | 2 | 2007 | 3539 | 0.13 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.12 | Why? |
| Dendritic Cells | 2 | 2017 | 1330 | 0.12 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2017 | 760 | 0.11 | Why? |
| HEK293 Cells | 3 | 2020 | 8394 | 0.11 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.11 | Why? |
| Cytomegalovirus Infections | 1 | 2017 | 667 | 0.11 | Why? |
| Seasons | 2 | 2021 | 4071 | 0.10 | Why? |
| Germany | 3 | 2021 | 9196 | 0.10 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.10 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.10 | Why? |
| Mice | 5 | 2018 | 21357 | 0.09 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2005 | 846 | 0.09 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.08 | Why? |
| Animals | 9 | 2020 | 78931 | 0.08 | Why? |
| Respiratory Tract Infections | 2 | 2010 | 6817 | 0.08 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.07 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2021 | 41 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| SARS Virus | 2 | 2007 | 13021 | 0.06 | Why? |
| Lymphoma, Mantle-Cell | 1 | 2021 | 109 | 0.05 | Why? |
| Periodicity | 1 | 2010 | 34 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2021 | 5762 | 0.05 | Why? |
| Neutralization Tests | 3 | 2021 | 6698 | 0.05 | Why? |
| Lymphoma, B-Cell | 1 | 2021 | 166 | 0.05 | Why? |
| Lymphocyte Depletion | 1 | 2021 | 293 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.05 | Why? |
| Liver | 1 | 2004 | 4007 | 0.05 | Why? |
| Humans | 20 | 2021 | 930598 | 0.05 | Why? |
| Fowlpox virus | 1 | 2017 | 8 | 0.05 | Why? |
| Coronavirus | 2 | 2010 | 18339 | 0.05 | Why? |
| Receptors, CXCR5 | 1 | 2017 | 35 | 0.05 | Why? |
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 65 | 0.05 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.04 | Why? |
| Cell Line | 3 | 2021 | 12040 | 0.04 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.04 | Why? |
| Drug Synergism | 1 | 2020 | 833 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2020 | 801 | 0.04 | Why? |
| Coculture Techniques | 1 | 2017 | 258 | 0.04 | Why? |
| Molecular Sequence Data | 1 | 2012 | 3198 | 0.04 | Why? |
| Immunity, Cellular | 2 | 2021 | 3614 | 0.04 | Why? |
| Reference Standards | 1 | 2020 | 1163 | 0.04 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.04 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 526 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Vaccination | 2 | 2018 | 19050 | 0.04 | Why? |
| Male | 9 | 2021 | 367725 | 0.04 | Why? |
| CHO Cells | 1 | 2017 | 831 | 0.04 | Why? |
| Viral Vaccines | 1 | 2007 | 7560 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Cricetulus | 1 | 2017 | 936 | 0.04 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2020 | 37182 | 0.03 | Why? |
| Aged | 5 | 2021 | 215776 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
| Models, Animal | 1 | 2007 | 788 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.03 | Why? |
| Chemokine CXCL10 | 1 | 2017 | 565 | 0.03 | Why? |
| Rituximab | 1 | 2021 | 1096 | 0.03 | Why? |
| Adult | 5 | 2021 | 244371 | 0.03 | Why? |
| Lentivirus | 1 | 2004 | 310 | 0.03 | Why? |
| Vero Cells | 2 | 2020 | 14117 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.03 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.03 | Why? |
| Interleukins | 1 | 2017 | 762 | 0.03 | Why? |
| Recombinant Fusion Proteins | 1 | 2007 | 919 | 0.03 | Why? |
| DNA, Viral | 1 | 2012 | 2521 | 0.03 | Why? |
| Peptide Fragments | 1 | 2012 | 2075 | 0.03 | Why? |
| Adenoviridae | 1 | 2017 | 1151 | 0.03 | Why? |
| Transfection | 1 | 2004 | 864 | 0.03 | Why? |
| Rabbits | 1 | 2004 | 1171 | 0.03 | Why? |
| Genetic Vectors | 1 | 2017 | 1600 | 0.03 | Why? |
| Amino Acid Sequence | 1 | 2012 | 6049 | 0.03 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2004 | 12361 | 0.03 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.03 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Macaca mulatta | 1 | 2017 | 3716 | 0.02 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.02 | Why? |
| Infant, Newborn | 2 | 2010 | 23105 | 0.02 | Why? |
| Drug Discovery | 1 | 2020 | 3092 | 0.02 | Why? |
| Virion | 1 | 2004 | 1444 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2004 | 3608 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Infant | 2 | 2010 | 30274 | 0.02 | Why? |
| Carcinoma, Hepatocellular | 1 | 2004 | 1222 | 0.02 | Why? |
| Vaccines, Synthetic | 1 | 2007 | 3231 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Child, Preschool | 2 | 2010 | 36283 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2017 | 4849 | 0.02 | Why? |
| Ambulatory Care | 1 | 2010 | 4947 | 0.02 | Why? |
| Outpatients | 1 | 2005 | 3417 | 0.01 | Why? |
| Liver Neoplasms | 1 | 2004 | 1666 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2020 | 6331 | 0.01 | Why? |
| Mutation | 1 | 2012 | 12376 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Kidney | 1 | 2004 | 3648 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Inpatients | 1 | 2005 | 5161 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2007 | 10998 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Incidence | 1 | 2010 | 25622 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Viral Load | 1 | 2005 | 15850 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Time Factors | 1 | 2005 | 31397 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Neoplasms | 1 | 2007 | 17251 | 0.01 | Why? |
| Pandemics | 1 | 2020 | 389249 | 0.00 | Why? |
Überla's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(160)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(172)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_